Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2003
12/03/2003EP1365793A2 Treatment of inflammatory bowel disease using growth factors
12/03/2003EP1365781A1 Acrochordon alleviation
12/03/2003EP1365762A1 Method for increasing leptin levels using nicotinic acid compounds
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1365752A2 Methods for the treatment of a traumatic central nervous system injury with e.g. allopregnanolone
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1027351B1 Phenanthroline derivatives
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003EP0980270B1 Dermal sheath tissue in wound healing
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1460021A Plaster preparation
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459313A Prepared Chinese medicine for treating various kinds of face spots
12/03/2003CN1459304A Health-care and beauty-improving product, and its prepn. method
12/03/2003CN1459285A Plaster for reunion of laceration of skin
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129446C Exterior applied medicine for treating burn
12/03/2003CN1129445C Burn treating Chinese medicine prepn.
12/03/2003CN1129433C Use of formyl amine for preparing composition for treating lipsotrichia
12/03/2003CN1129425C Medicated tissue paper product
12/03/2003CN1129421C Spot removing antiwrinkle cream
12/03/2003CA2431795A1 Topical and oral administration of a composition containing pelargonium graveolens for diagnosis and treatment of various neuralgias and other conditions
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656959 PDE IV inhibiting pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
12/02/2003CA2326625C Topical liquid composition for promoting hair growth and process of manufacturing thereof
12/02/2003CA2075201C Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
11/2003
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097641A2 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097613A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097577A1 Chemical compound consisting of a nitrogenous chalcone derivative, method of producing one such chemical compound and filtering and/or cosmetic composition containing same
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097072A1 Chloasma amelioration composition and dullness amelioration composition
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097061A1 External preparation for allergic diseases
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003097042A1 Pgd2 receptor antagonist
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097030A1 Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
11/27/2003WO2003097016A1 Agent delivery system
11/27/2003WO2003097010A1 Medicinal preparation in a colloid for topical application in the therapy and prophylaxis of states of pain and itching
11/27/2003WO2003097001A1 Methods and compositions employing a dialkyl amide
11/27/2003WO2003096973A2 A direct cellular energy delivery system
11/27/2003WO2003082189A3 Method for producing pseudo islets
11/27/2003WO2003066594A3 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003041651A3 Allatoin-containing skin cream
11/27/2003WO2003040119A8 Angiogenesis inhibitors
11/27/2003WO2003039446A3 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003009802A3 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2003005971A3 Tetracycline compounds having target therapeutic activities
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1065